[1]于 琦,李 臻,李 鑫,等.纵隔巨大神经内分泌肿瘤综合治疗1例[J].介入放射学杂志,2022,31(05):523-524.
　YU Qi,LI Zhen,LI Xin,et al.Comprehensive treatment of mediastinal giant neuroendocrine neoplasms： report of one case[J].journal interventional radiology,2022,31(05):523-524.
点击复制

纵隔巨大神经内分泌肿瘤综合治疗1例()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
31
期数:
2022年05
页码:
523-524
栏目:
病例报告
出版日期:
2022-07-19

文章信息/Info

Title:
Comprehensive treatment of mediastinal giant neuroendocrine neoplasms： report of one case
作者:
于 琦;  李 臻;  李 鑫;  纪 坤;  石 洋;  詹鹏超;  叶书文;  谢炳灿;  韩新巍
Author(s):
YU Qi;  LI Zhen;  LI Xin;  JI Kun;  SHI Yang;  ZHAN Pengchao;  YE Shuwen;  XIE Bingcan;  HAN Xinwei.
Department of Interventional Radiology， First Affiliated Hospital， Zhengzhou University， Zhengzhou， Henan Province 450052， China
关键词:
【关键词】 神经内分泌肿瘤;  经动脉化疗栓塞术;  载药微球
文献标志码:
A

参考文献/References:

［1］ 邱旭东，刘 猛，刘 青，等． 903例神经内分泌肿瘤发病部位与病理特征分析［J］． 中华胃肠外科杂志， 2017， 20：993- 996．
［2］ Reidy DL， Tang LH， Saltz LB. Treatment of advanced disease in patients with well- differentiated neuroendocrine tumors［J］. Nat Clin Pract Oncol， 2009， 6：143- 152.
［3］ 徐建明，梁后杰，秦叔逵，等． 中国临床肿瘤学会神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识（2016年版）［J］． 临床肿瘤学杂志， 2016， 21：927- 946．
［4］ Bargellini， I，VivaldiC，Lorenzoni G， et al. Neuroendocrine liver metastases［J］. Cardiovasc Intervent Radiol， 2019， 42：1053- 1054.
［5］ Li ZS， Li Q. The latest 2010 WHO classification of tumors of digestive system［J］. Zhonghua Bing Li Xue Za Zhi， 2011， 40：51- 54.
［6］ Brenner B， Shah MA， Gonen M， et al. Small- cell carcinoma of the gastrointestinal tract： a retrospective study of 64 cases［J］. Br J Cancer， 2004， 90： 1720- 1726.
［7］ 李 鑫，李 臻，李 刚，等． 载药微球化疗栓塞治疗下肢梭形细胞肉瘤1例［J］． 介入放射学杂志， 2018， 27：111- 113．
［8］ 纪 坤，李 臻，李 鑫，等． 载药微球化疗栓塞治疗巨大扁桃体鳞癌1例［J］． 介入放射学杂志， 2020， 29：219- 220．
［9］ Li Z， Ji K， Bai L， et al. A novel application of drug- eluting transarterial chemoembolization in treating non- liver cancers［J］. Medicine（Baltimore）， 2020， 99： e20878.
［10］ Okita NT， Kato K， Takahari D， et al. Neuroendocrine tumors of the stomach： chemotherapy with cisplatin plus irinotecan is effective for gastric poorly- differentiated neuroendocrine carcinoma［J］. Gastric Cancer， 2011， 14： 161- 165.

相似文献/References:

[1]程洪涛,郭晨阳,黎海亮,等.ＴＡＣＥ联合射频消融治疗原发性肝癌疗效的影响因素分析[J].介入放射学杂志,2012,(03):216.
　,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ＣＴｇｕｉｄｅｄ ｐｅｒｃｕｔａｎｅｏｕｓ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａｎ ａｎａｌｙｓｉｓ ｏｆ ｆａｃｔｏｒｓ ａｆｆｅｃｔｉｎｇ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｒｅｓｕｌｔ [J].journal interventional radiology,2012,(05):216.
[2]房星宇,于 淼,杨倚天,等. 肝动脉化疗栓塞及射频消融治疗胰腺神经内分泌肿瘤肝转移的疗效和生存分析[J].介入放射学杂志,2013,(05):377.
　FANG Xing? yu,YU Miao,YANG Yi? tian,et al. Transarterial chemoembolization and radiofrequency ablation for liver metastases from pancreatic neuroendocrine tumors： an analysis of clinical effect and survival[J].journal interventional radiology,2013,(05):377.
[3]姚雪松,闫 东,曾辉英,等.经动脉化疗栓塞治疗肝细胞癌疗效评估中C臂CT技术应用[J].介入放射学杂志,2014,(07):588.
　YAO Xue- song,YAN Dong,ZENG Hui- ying,et al.The application of C- arm CT imaging technique in evaluating the efficacy of TACE for hepatocellular carcinoma[J].journal interventional radiology,2014,(05):588.
[4]陈呈世,胡鸿涛,肖金成,等.ABCR评分对肝细胞癌患者再次行TACE治疗的指导作用[J].介入放射学杂志,2016,(10):915.
　CHEN Cheng- shi,HU Hong- tao,XIAO Jin- cheng,et al.The value of ABCR score in guiding the second time of TACE treatment for patients with hepatocellular carcinoma[J].journal interventional radiology,2016,(05):915.
[5]江 旭,李 慧,刘 航,等.影响肝细胞癌切除术后早期复发及生存的危险因素分析 [J].介入放射学杂志,2018,27(03):215.
　JIANG Xu,LI Hui,LIU Hang,et al.The risk factors affecting early recurrence and survival after surgical resection of hepatocellular carcinoma[J].journal interventional radiology,2018,27(05):215.
[6]王万胜,王 晨,沈 健,等.复合125I粒子植入技术联合TACE治疗肝癌合并门静脉癌栓[J].介入放射学杂志,2021,30(07):680.
　WANG Wansheng,WANG Chen,SHEN Jian,et al.Complex 125I seed implantation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma complicated by portal vein tumor thrombus[J].journal interventional radiology,2021,30(05):680.
[7]侯忠衡,张 磊,王 祁,等.术前血清前白蛋白对TACE治疗不可切除肝细胞癌患者预后的预测价值 [J].介入放射学杂志,2022,31(06):587.
　HOU Zhongheng,ZHANG Lei,WANG Qi,et al.The clinical value of preoperative serum prealbumin level in predicting the prognosis of patients with inoperable HCC after receiving TACE： a multicenter retrospective study[J].journal interventional radiology,2022,31(05):587.
[8]宋 震,李园园,王文刚,等.TACE联合酪氨酸激酶抑制剂和卡瑞利珠单抗对中晚期肝癌的疗效与安全性[J].介入放射学杂志,2023,32(06):549.
　SONG Zhen,LI Yuanyuan,WANG Wengang,et al.Efficacy and safety of TACE combined with TKIs plus camrelizumab for the treatment of intermediate and advanced hepatocellular carcinoma[J].journal interventional radiology,2023,32(05):549.
[9]张 辉,张庆桥,袁 磊,等.CalliSpheres D-TACE与-TACE治疗原发性肝癌对肝纤维化和肝功能的影响[J].介入放射学杂志,2024,33(03):259.
　ZHANG Hui,ZHANG Qingqiao,YUAN Lei,et al.The effect of CalliSpheres DEB-TACE and c-TACE on liver fibrosis and liver function in treating primary hepatocellular carcinoma[J].journal interventional radiology,2024,33(05):259.
[10]吴迪,郑琳.载药微球栓塞治疗在肝癌全程管理中的临床应用进展[J].介入放射学杂志,2024,33(08):921.
　WU Di,ZHENG Lin..Application progress of drug-loaded microspheres embolization therapy in the clinical full-process management of hepatocellular carcinoma[J].journal interventional radiology,2024,33(05):921.

备注/Memo

备注/Memo:
（收稿日期：2021- 01- 06）
（本文编辑：俞瑞纲）
更新日期/Last Update: 2022-07-19